Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker XFOR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Adam R. Craig Executive Chairman, Director | XFOR X4 Pharmaceuticals, Inc. | Buy | 4,600 | $2.58 | $11.9K Buy | Form 4 ↗ |
| Aug 12, 2026 | John Volpone President | XFOR X4 Pharmaceuticals, Inc. | Sale | 24,576 | $4.44 | $109.1K Sale | Form 4 ↗ |
| Aug 12, 2026 | Adam R. Craig Executive Chairman, Director | XFOR X4 Pharmaceuticals, Inc. | Sale | 47,436 | $4.44 | $210.6K Sale | Form 4 ↗ |
| Jun 30, 2026 | David Kirske Chief Financial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 8,543 | $4.26 | $36.4K Sale | Form 4 ↗ |
| May 12, 2026 | David Kirske Chief Financial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 16,961 | $4.29 | $72.8K Sale | Form 4 ↗ |
| Oct 23, 2025 | Adam R. Craig Executive Chairman, Director | XFOR X4 Pharmaceuticals, Inc. | Buy | 86,206 | $2.90 | $250.0K Buy | Form 4 ↗ |
| Jan 24, 2025 | Paula Ragan President and CEO, Director | XFOR X4 Pharmaceuticals, Inc. | Sale | 76,473 | $0.45 | $34.4K Sale | Form 4 ↗ |
| Jan 24, 2025 | Adam S. Mostafa Chief Financial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 74,773 | $0.45 | $33.6K Sale | Form 4 ↗ |
| Jan 24, 2025 | Mark Baldry Chief Commercial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 29,159 | $0.45 | $13.1K Sale | Form 4 ↗ |
| Jan 24, 2025 | Mary DiBiase Chief Operating Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 22,258 | $0.45 | $10.0K Sale | Form 4 ↗ |
| Jan 24, 2025 | Christophe Arbet-Engels Chief Medical Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 11,624 | $0.45 | $5,231 Sale | Form 4 ↗ |
| Nov 15, 2024 | Mark Baldry Chief Commercial Officer | XFOR X4 Pharmaceuticals, Inc. | Buy | 13,404 | $0.34 | $4,557 Buy | Form 4 ↗ |
| Nov 15, 2024 | Paula Ragan President and CEO, Director | XFOR X4 Pharmaceuticals, Inc. | Sale | 31,897 | $0.39 | $12.4K Sale | Form 4 ↗ |
| Oct 15, 2024 | Paula Ragan President and CEO, Director | XFOR X4 Pharmaceuticals, Inc. | Sale | 31,897 | $0.56 | $17.9K Sale | Form 4 ↗ |
| Oct 7, 2024 | Adam S. Mostafa Chief Financial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 230,645 | $0.55 | $126.9K Sale | Form 4 ↗ |
| Oct 7, 2024 | Mark Baldry Chief Commercial Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 11,127 | $0.58 | $6,454 Sale | Form 4 ↗ |
| Oct 7, 2024 | Paula Ragan President and CEO, Director | XFOR X4 Pharmaceuticals, Inc. | Sale | 239,436 | $0.55 | $131.7K Sale | Form 4 ↗ |
| Oct 7, 2024 | Mary DiBiase Chief Operating Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 67,695 | $0.57 | $38.6K Sale | Form 4 ↗ |
| Oct 7, 2024 | Arthur Taveras Chief Scientific Officer | XFOR X4 Pharmaceuticals, Inc. | Sale | 76,920 | $0.56 | $43.1K Sale | Form 4 ↗ |
| May 17, 2024 | Mark Baldry Chief Commercial Officer | XFOR X4 Pharmaceuticals, Inc. | Buy | 21,646 | $0.68 | $14.7K Buy | Form 4 ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances